American Journal of Roentgenology, Vol 169, 1051-1059, Copyright © 1997 by American Roentgen Ray Society

ARTICLES

MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT

RN Low and IR Francis
Sharp and Children's MRI Center, San Diego, CA, USA.

OBJECTIVE: To determine an optimal MR imaging technique and pulse sequence for evaluating mural and serosal disease of the gastrointestinal tract, we administered 2% oral barium sulfate and obtained fat-suppressed gadolinium-enhanced breath-hold fast multiplanar spoiled gradient-recalled (FMPSPGR) MR images. We then compared these images with spin-echo T1-weighted and T2-weighted fast spin-echo MR images and with CT images. SUBJECTS AND METHODS: Thirty- one patients with suspected diseases of the gastrointestinal tract were imaged with spin-echo T1-weighted, fast spin-echo T2-weighted, and fat- saturated gadolinium-enhanced FMPSPGR MR imaging. Before undergoing MR imaging, all patients received 1350 ml of 2% barium sulfate oral contrast media. For CT scans, patients received 120 ml of iodinated i.v. contrast material and 2% barium sulfate oral contrast material. CT and MR images were retrospectively and independently reviewed by two radiologists for ability to see normal bowel wall, for the presence of abnormal gastrointestinal tract mural thickening or enhancement, and for overall gastrointestinal tract visualization. Findings were correlated with surgical findings, endoscopy, and barium studies. RESULTS: Ten patients had benign disease, 16 had malignant gastrointestinal tract disease, and five had no gastrointestinal tract abnormalities. In 94% of patients, the gadolinium- and barium-enhanced FMPSPGR MR images were superior to CT and spin-echo MR sequences for depicting the wall of the normal bowel (p < .001). For the two observers, the FMPSPGR MR images with i.v. and oral contrast material were seen as revealing 94% and 95% of bowel segments with malignant or inflammatory mural thickening or serosal tumor. In comparison, CT revealed 64% and 72% (p < .01 and p < .0001, respectively), fast spin- echo T2-weighted MR images revealed 21% and 28% (p < .0001), and T1- weighted MR images revealed 17% and 18% (p < .0001). The gadolinium- and barium-enhanced MR images were preferred for overall gastrointestinal tract visualization in 65% of patients compared with 1% for CT scans (p < .001). In 32% of patients, the enhanced MR images were equivalent to CT images. CONCLUSION: MR evaluation of the gastrointestinal tract requires bowel distention with oral contrast material as well as motion reduction techniques, including glucagon and rapid gradient-echo pulses that allow breath-hold imaging. Fat- suppressed gadolinium-enhanced FMPSPGR MR imaging with diluted barium oral contrast media is effective for imaging benign and malignant mural and serosal abnormalities of the gastrointestinal tract.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Horsthuis, S. Bipat, R. J. Bennink, and J. Stoker Inflammatory Bowel Disease Diagnosed with US, MR, Scintigraphy, and CT: Meta-analysis of Prospective Studies Radiology, April 1, 2008; 247(1): 64 - 79. [Abstract] [Full Text] [PDF]

				A C Planner, A Phillips, and H K Bungay The role of imaging in small bowel disease Imaging, December 1, 2006; 18(4): 228 - 256. [Abstract] [Full Text] [PDF]

				M V Pakkal and M Balogun Imaging of ovarian cancer Imaging, August 1, 2006; 18(1): 20 - 27. [Abstract] [Full Text] [PDF]

				A. Furukawa, T. Saotome, M. Yamasaki, K. Maeda, N. Nitta, M. Takahashi, T. Tsujikawa, Y. Fujiyama, K. Murata, and T. Sakamoto Cross-sectional Imaging in Crohn Disease RadioGraphics, May 1, 2004; 24(3): 689 - 702. [Abstract] [Full Text] [PDF]

				R. N. Low, S. C. Chen, and R. Barone Distinguishing Benign from Malignant Bowel Obstruction in Patients with Malignancy: Findings at MR Imaging Radiology, July 1, 2003; 228(1): 157 - 165. [Abstract] [Full Text] [PDF]

				D. M. Koh, Y. Miao, R. J. S. Chinn, Z. Amin, R. Zeegen, D. Westaby, and J. C. Healy MR Imaging Evaluation of the Activity of Crohn's Disease Am. J. Roentgenol., December 1, 2001; 177(6): 1325 - 1332. [Abstract] [Full Text] [PDF]

				P. Prassopoulos, N. Papanikolaou, J. Grammatikakis, M. Rousomoustakaki, T. Maris, and N. Gourtsoyiannis MR Enteroclysis Imaging of Crohn Disease RadioGraphics, October 1, 2001; 21(90001): S161 - 172. [Abstract] [Full Text] [PDF]

				E. S. Siegelman and E. K. Outwater Tissue Characterization in the Female Pelvis by Means of MR Imaging Radiology, July 1, 1999; 212(1): 5 - 18. [Abstract] [Full Text]

				R. N. Low, R. C. Semelka, S. Worawattanakul, G. D. Alzate, and J. S. Sigeti Extrahepatic Abdominal Imaging in Patients with Malignancy: Comparison of MR Imaging and Helical CT, with Subsequent Surgical Correlation Radiology, March 1, 1999; 210(3): 625 - 632. [Abstract] [Full Text]

				R. N. Low, C. P. Sebrechts, D. A. Politoske, M. T. Bennett, S. Flores, R. J. Snyder, and J. H. Pressman Crohn Disease with Endoscopic Correlation: Single-Shot Fast Spin-Echo and Gadolinium-enhanced Fat-suppressed Spoiled Gradient-Echo MR Imaging Radiology, March 1, 2002; 222(3): 652 - 660. [Abstract] [Full Text] [PDF]